SIS
NVAX icon

Strategic Investment Solutions’s Novavax NVAX Stock Holding History

Strategic Investment Solutions’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5
Closed -$32 – 630
2025
Q2 		$32 Buy
+5
New +$33 ﹤0.01% 593
2023
Q4 		– Sell
-945
Closed -$7.55K – 1166
2023
Q3 		$7.55K Buy
945
+930
+6,200% +$7.43K ﹤0.01% 671
2023
Q2 		$139 Hold
15
– – ﹤0.01% 838
2023
Q1 		$104 Buy
+15
New +$138 ﹤0.01% 991

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Strategic Investment Solutions's NVAX Position: Q3 2025 in Review

Strategic Investment Solutions sold out of Novavax (NVAX) in Q3 2025, closing a stake of 5 shares — an estimated $32 sold.

Strategic Investment Solutions first reported a position in NVAX in Q1 2023 and held it in 4 quarters. The position peaked at $7.55K in Q3 2023. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Strategic Investment Solutions reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
  • Strategic Investment Solutions sold 5 Novavax shares in Q3 2025, an estimated $32.
  • Strategic Investment Solutions first reported a position in Novavax in Q1 2023 and held it in 4 quarters.
  • Strategic Investment Solutions's Novavax position peaked at $7.55K in Q3 2023.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Strategic Investment Solutions's 13F filing for Q3 2025, filed 3 Dec 2025.